Without the pandemic trade, Ackman's portfolio would be down on the year.The market traded higher Monday on hopes the vaccine will lead to reopening of businesses and sectors.Ackman is "bearish" on the vaccine news, as he said it could lead to people taking the virus less seriously.A difficult few months are ahead before the recovery takes off, in the investor's view. If the fund is owned inside a tax-favored account like an IRA or retirement account, the sale will not generate a taxable gain. Fans can try the new favorite on shelf at Kroger stores throughout Ohio, Kentucky, and Tennessee at an SRP of $9.99 per six pack. In fact, over the past five years alone, Plug has grown its revenues at about a 29% compounded rate. We believe the improved balance sheet and cash flow is allowing the company to make investments in areas of the business that have been previously overlooked, and may have been under-contributing as a result,” Dayal opined.In-line with these comments, Dayal rates this stock a Buy along with a $16 price target. COVINGTON, Ky., Aug. 13, 2020 /PRNewswire/ -- VIVE Hard Seltzer, a widely-recognized regional velocity power player, has once again challenged the category by crafting a … The point of a profit-seeking venture like Plug should in theory be not just to "sell stuff," but to earn profits from selling stuff -- and it's here that Plug Power has historically fallen short. The content is intended to be used for informational purposes only. The sum of all automotive sales revenue for Tesla was $7.6 billion.Meanwhile, with second-quarter revenue of $526.3 million, higher by 139.54% from the same period last year, Shanghai-based EV maker Nio continues to garner investor's attention in the EV space.Be sure to follow Benzinga for Nio's third-quarter earnings, expected Nov. 17 after market close.Levels of sentiment were extraordinarily tight for this study as traders and investors expressed an near-equal weighted confidence for both EV makers.49.2% of respondents said Tesla stock will grow the most by 2025. All rights reserved. Its core brands attract 150 million readers every month, and over 6.5 million paid subscriptions.In a news environment as fast-paced and chaotic as 2020 has been, the NYT has reaped the benefit of people’s need to know. The billionaire investor talked about his latest wager on what he believes will be a rough stretch for American corporations due to the economic hit from the coronavirus pandemic. The Covington, KY brewery will begin distributing six-packs of the pumpkin spice hard seltzer in September 2020. "What's fascinating is the same bet we put on eight months ago is available on the same terms as if there had never been a fire and on the probability that the world is going to be fine," he reportedly said.Related Link: Bloomberg Denies Report Of Minority Stake Sale Talks With Bill Ackman's SPACWhy It's Important: Ackman turned a $27-million bet on the same idea into $2.6 billion earlier this spring.Ackman predicted that cases of coronavirus would spike and the market would sell off.The profit made from Ackman's first pandemic trade was put back into portfolio companies like Berkshire Hathaway (NYSE: BRK-A)(NYSE: BRK-B), Hilton Worldwide (NYSE: HLT), Restaurant Brands International (NYSE: QSR), Lowe's Corporation (NYSE: LOW) and Starbucks Corporation (NASDAQ: SBUX).As of Oct. 31, Ackman's hedge fund is up 44% year-to-date. Plug Power (PLUG) is a strange sort of business. While acceleration to 38% certainly won't be easy, Plug's history of revenue growth suggests it does lie within the realm of possibility.And yet, that's not really the point, is it? Famed hedge fund manager Bill Ackman had his best trade of all-time earlier this year when he bet against the market, and he's placing a similar bet again despite the market optimism surrounding the development of a COVID-19 vaccine.What Happened: Business Insider reports that Bill Ackman placed a new hedge against the market Monday.The news came on the same day Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced a 90% efficacy rate for their COVID-19 vaccine candidate.